Ventilator Settings Explained: AC, SIMV, RR & FiO2 Guide

Oxygen and carbon dioxide must cross multiple layers to exchange between alveoli and capillaries: (1) surfactant layer (fluid interface between gas and liquid), (2) alveolar cell wall, (3) basement membrane of alveolar cells, (4) connective tissue proteins, (5) basement membrane of capillary cells, (6) capillary cell wall, (7) plasma (liquid portion of blood), and finally (8) red blood cells. Carbon dioxide follows the reverse pathway during exhalation.

Gas exchange occurs at two sites: the respiratory membrane (alveolar-capillary interface) and tissue level. Oxygen diffuses from alveoli (104 mmHg) to pulmonary capillaries (40 mmHg), while CO2 diffuses from capillaries (45 mmHg) to alveoli (40 mmHg). The diffusion membrane consists of three layers: alveolar epithelium, capillary endothelium, and basement membrane, with total thickness less than 1 mm. Three factors affect diffusion rate: partial pressure gradient, gas solubility, and membrane thickness. CO2 diffuses 20-25 times faster than oxygen due to its higher solubility, despite having a lower partial pressure gradient. Partial pressures vary: atmospheric O2 = 159 mmHg, alveolar O2 = 104 mmHg, pulmonary arterial O2 = 40 mmHg, pulmonary venous O2 = 95 mmHg, tissue O2 = 40 mmHg.

The alveolar-capillary membrane consists of six layers: alveolar fluid, alveolar epithelium, alveolar basement membrane, interstitial fluid, capillary basement membrane, and capillary endothelium. Oxygen diffuses through this membrane via simple diffusion (no ATP or carriers needed), making gas exchange highly efficient. This passive process allows billions of oxygen molecules to cross the membrane daily without energy expenditure. The structure enables rapid oxygen uptake and CO2 release, facilitating the continuous exchange necessary for cellular respiration.

Gas diffusion across the alveolar-capillary membrane depends on the pressure gradient (gases move from high to low concentration), the gas's solubility (CO2 is 20 times more soluble than O2), the surface area available for exchange, and the membrane thickness (normally 0.3-0.6 micrometers); according to Fick's Law, the rate of gas transfer is proportional to the pressure gradient and surface area, and inversely proportional to membrane thickness, which explains why conditions like pulmonary edema that increase membrane thickness disproportionately impair oxygen diffusion while CO2 diffusion remains relatively preserved due to its higher solubility.

Gas exchange occurs at the alveolar-capillary interface where oxygen diffuses from alveoli to blood and carbon dioxide from blood to alveoli. Fick's Law describes diffusion rate based on surface area, membrane thickness, and partial pressure gradient. CO2 diffuses about 20 times faster than oxygen due to higher solubility. Oxygen is transported primarily bound to hemoglobin (98.5%) with small amount dissolved in plasma (1.5%). Each hemoglobin molecule binds four oxygen molecules. Carbon dioxide is transported as bicarbonate (70%), carbaminohemoglobin (23%), and dissolved (7%). Carbonic anhydrase in red blood cells catalyzes CO2 conversion to bicarbonate. The chloride shift maintains electrical balance.

An Arterial Blood Gas (ABG) test measures blood pH, partial pressure of arterial carbon dioxide (PaCO2), bicarbonate (HCO3), oxygen saturation, and base excess to assess acid-base balance; the body maintains pH through respiratory compensation (lungs regulating CO2 levels) and metabolic compensation (kidneys regulating bicarbonate), and ABG interpretation follows a two-step process: first determine if the patient is in acidosis (pH < 7.35) or alkalosis (pH > 7.45), then identify whether the respiratory or metabolic system is responsible by examining PaCO2 and bicarbonate levels, with all three values pointing in the same direction indicating a metabolic problem and opposite directions indicating a respiratory problem.

Arterial blood gas (ABG) analysis provides critical information about acid-base status. Key parameters include pH (normal 7.35-7.45), PCO2 (normal 35-45 mmHg), PO2 (normal 80-100 mmHg), HCO3- (normal 22-26 mEq/L), and BE (normal -2 to +2.5 mEq/L). PCO2 reflects respiratory component, while HCO3- and BE reflect metabolic component. Interpretation involves analyzing relationships between these parameters. If pH is abnormal, the primary disturbance is identified by comparing PCO2 and HCO3- changes. If PCO2 changes proportionally with HCO3-, the primary disturbance is respiratory. If HCO3- changes disproportionately, the primary disturbance is metabolic. Compensation is identified when the secondary parameter changes in the expected direction but does not fully normalize pH.

ABG interpretation requires knowing three key numbers: pH (7.35-7.45), HCO3 (bicarbonate, 22-26), and PaCO2 (35-45). Remember pH and PaCO2 both end in 35. Alkalosis (high pH) causes irritability, high RR, BP, and HR. Acidosis (low pH) shows bradycardia, lethargy, hypotension, and coma. Causes of alkalosis include vomiting, suction, and hyperventilation. Metabolic acidosis is caused by excessive diarrhea (since bowel movements are basic). To interpret ABGs, combine arrows: if pH and HCO3 move together, it's metabolic; if pH and PaCO2 move together, it's respiratory.

This comprehensive guide covers arterial blood gas (ABG) interpretation for clinical practice. Normal values: pH 7.35-7.45, PaCO2 35-45 mmHg, PaO2 80-100 mmHg, HCO3- 22-26 mEq/L. The three-step interpretation process: (1) identify acidosis (pH <7.35) or alkalosis (pH >7.45), (2) assess PaCO2 relationship with pH, (3) evaluate HCO3- relationship with pH. Four primary disorders: metabolic acidosis (low pH, low HCO3-), metabolic alkalosis (high pH, high HCO3-), respiratory acidosis (low pH, high PaCO2), respiratory alkalosis (high pH, low PaCO2). Compensation mechanisms include chemical buffers, respiratory adjustments, and renal regulation. Compensation formulas: metabolic acidosis expected PaCO2 = (1.5 × HCO3-) + 8 ± 2; metabolic alkalosis expected PaCO2 = (0.7 × HCO3-) + 21 ± 2; respiratory acidosis acute HCO3- increase = 1 mEq/L per 10 mmHg PaCO2 increase, chronic = 4 mEq/L; respiratory alkalosis acute HCO3- decrease = 2 mEq/L per 10 mmHg PaCO2 decrease, chronic = 5 mEq/L. Mixed disorders occur when two values fall outside normal ranges.

Arterial blood gas (ABG) analysis measures pH, PaCO2, HCO3, PaO2, and base excess to assess ventilation and acid-base status; normal values are pH 7.35-7.45, PaCO2 35-45 mmHg, HCO3 22-26 mEq/L, and PaO2 80-100 mmHg; when pH is low (acidosis), elevated PaCO2 indicates respiratory acidosis, while elevated HCO3 indicates metabolic acidosis, and the relationship between pH and PaCO2 is inversely proportional while pH and HCO3 are directly proportional.

Non-invasive respiratory support offers significant advantages over invasive mechanical ventilation by avoiding complications including barotrauma, lung injury, laryngeal complications, diaphragmatic weakness, and hemodynamic instability. Three main modalities exist: conventional NIV/BiPAP using full face masks, heated high flow nasal cannula delivering 40-60 L/min with CPAP effect, and helmet ventilation. Gold standard indications include acute chronic hypercapnic COPD exacerbations, cardiogenic pulmonary edema, and other acute respiratory failures. Contraindications include airway protection issues, hemodynamic instability, facial trauma, and morbid obesity. Success requires recognizing failure within 1-2 hours and transitioning to invasive ventilation when needed.

Invasive mechanical ventilation differs from non-invasive ventilation (CPAP or BiPAP). Non-invasive ventilation has therapeutic roles for treating pulmonary edema due to heart failure exacerbation, hypercapnic respiratory failure, and increased work of breathing due to COPD and asthma exacerbations. A general rule is to use non-invasive ventilation for quickly reversible conditions expected to improve within 24-48 hours with medical therapies. However, invasive mechanical ventilation becomes necessary if non-invasive ventilation fails. CPAP and BiPAP should not be used when patients are altered and unable to protect their airway, have excessive secretions, have recent upper airway surgery or facial trauma, or have untreated pneumothorax.

Mechanical ventilators (invasive ventilation) are used for patients who cannot breathe at all (apneic) or have minimal breathing effort, as they perform complete ventilation including both inspiration and expiration; in contrast, CPAP/BiPAP systems (non-invasive ventilation) provide respiratory support for patients who have spontaneous breathing effort, offering assistance rather than complete ventilation.

Mechanical ventilation can be classified as invasive or non-invasive based on whether an artificial airway is placed inside the patient's body. Non-invasive ventilation uses devices such as nasal cannulas, nasal masks, or full-face masks that sit on the outside of the face without entering the body. These methods are delivered through specialized non-invasive ventilators (such as BiPAP or CPAP machines). Invasive ventilation requires placing an artificial airway inside the body, either through an endotracheal tube (inserted through the mouth or nose) or through a tracheostomy (surgical opening in the trachea). Both endotracheal tubes and tracheostomy tubes are considered invasive airways because they penetrate the body's natural barriers.

Non-invasive positive pressure ventilation includes CPAP (continuous positive airway pressure) delivering single pressure during both inhalation and exhalation, primarily for obstructive sleep apnea; and BiPAP (bilevel positive airway pressure) delivering higher inspiratory pressure and lower expiratory pressure, better tolerated and preferred for COPD patients and those with impending respiratory failure. When non-invasive methods fail, mechanical ventilation becomes necessary. Mechanical ventilation ensures adequate oxygenation, facilitates CO2 removal to prevent acidosis, reduces work of breathing on respiratory muscles, and decreases overall metabolic demand. The choice between non-invasive and invasive methods depends on patient tolerance, underlying condition severity, and response to prior interventions.